Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Study explores the social impact of COVID-19 symptoms among female long haulers

A new study analyzed the impact of long-COVID on women long haulers with respect to various aspects of their social life.

14 Feb 2022

Study shows expression of viral proteases may be used to quantitate SARS-CoV-2 infected cells

A new study describes a new method to quantify SARS-CoV-2 infection, which is much simpler and faster compared to existing methods.

14 Feb 2022

Why millions on Medicaid are at risk of losing coverage in the months ahead

The Biden administration and state officials are bracing for a great unwinding: millions of people losing their Medicaid benefits when the pandemic health emergency ends. Some might sign up for different insurance. Many others are bound to get lost in the transition.

14 Feb 2022

Study finds mRNA vaccines induce poor neutralizing antibody response against SARS-CoV-2 variants in dialysis patients

Scientists studied plasma samples from 130 hemodialysis (HD) and 13 peritoneal dialysis patients and showed a poor neutralizing and rapidly decaying antibody response to mRNA vaccines in such individuals.

14 Feb 2022

COVID-19 health warnings and regulation in public signage encourage social engagement

The use of COVID-19 health warnings and regulation in posters and public signage has effectively turned much of the responsibility and policing of compliance back on individuals, say sociology experts at Flinders University.

14 Feb 2022

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

In a study posted to the bioRxiv* preprint server, a team of researchers from the United States evaluated the protective effect of the preclinical version of the current Moderna Omicron-targeted mRNA-1273.529 vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron infection in mice.

14 Feb 2022

Study looks at potential impact of BBIBPCorV and CoronaVac SARS-CoV-2 vaccines on thyroid

In a recent study posted to Preprints with The Lancet* server, a team of researchers from China performed a serology study of thyroid function and antithyroid antibody levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-vaccinated recipients and further evaluated their correlation with SARS-CoV-2 neutralizing antibodies (NAbs) levels.

14 Feb 2022

Nitazoxanide shows promise for COVID-19 treatment in animal model

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that Nitazoxanide (NTZ), an oral drug, broadly inhibits replication of several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in preclinical models of infection.

13 Feb 2022

Wearable sensors for COVID-19 mitigation

In a recent study posted to the medRxiv* pre-print server, researchers simulated several wearable sensor deployment scenarios to demonstrate the potential of digital contact tracing technology in mitigating the coronavirus disease 2019 (COVID-19) pandemic.

13 Feb 2022

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

A recent paper by researchers from Australia, currently available on the medRxiv* preprint server, shows how Immunoglobulin A (IgA) antibodies in individuals who were infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contribute to the neutralization of the virus and its variants, even though this response is heterogeneous and less potent when compared to IgG antibodies.

13 Feb 2022

Assessing potential allergic reactions in COVID-19 vaccinated patients

Researchers analyze suspected reactions in patients vaccinated with the first and/or second dose of SARS-CoV-2 vaccines.

13 Feb 2022

Real world evidence on acquired immunity from vaccines and SARS-CoV-2 infection

Researchers assess the incidence of SARS-CoV-2 breakthrough cases and reinfections among unvaccinated and vaccinated individuals.

13 Feb 2022

Study examines the viral dynamics of Hong Kong's four SARS-CoV-2 waves

Researchers evaluate the efficiency of COVID-19 elimination strategies implemented in Hong Kong.

13 Feb 2022

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

At the February 11, 2022 opening of the Conference on Retroviruses and Opportunistic Infection, researchers at University of California San Diego School of Medicine presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by "drug tourism" unabated by the closure of the international border due to the COVID-19 pandemic.

12 Feb 2022

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Cancer patients undergoing active treatment were more likely to believe misinformation related to COVID-19 than those without a history of cancer, according to a new study led by researchers at Virginia Commonwealth University.

12 Feb 2022

New government fund will provide holidays for more than 800 families facing difficult times

Families struggling financially, or facing illness, isolation or bereavement, will have an opportunity for a weekend break thanks to a new government fund.

11 Feb 2022

Identifying and targeting ‘fence-sitters’ early in pandemic could help reduce vaccine hesitancy

Identifying adults who are ambivalent about vaccines early in a pandemic and finding community leaders who can help spread reliable information within their communities could help reduce vaccine hesitancy, according to a new University of Michigan study.

11 Feb 2022

Pandemic News and Research

Further Reading

Study explores the social impact of COVID-19 symptoms among female long haulers

Study shows expression of viral proteases may be used to quantitate SARS-CoV-2 infected cells

Why millions on Medicaid are at risk of losing coverage in the months ahead

Study finds mRNA vaccines induce poor neutralizing antibody response against SARS-CoV-2 variants in dialysis patients

COVID-19 health warnings and regulation in public signage encourage social engagement

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

Study looks at potential impact of BBIBPCorV and CoronaVac SARS-CoV-2 vaccines on thyroid

Nitazoxanide shows promise for COVID-19 treatment in animal model

Wearable sensors for COVID-19 mitigation

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

Assessing potential allergic reactions in COVID-19 vaccinated patients

Real world evidence on acquired immunity from vaccines and SARS-CoV-2 infection

Study examines the viral dynamics of Hong Kong's four SARS-CoV-2 waves

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

New government fund will provide holidays for more than 800 families facing difficult times

Identifying and targeting ‘fence-sitters’ early in pandemic could help reduce vaccine hesitancy

New insights into the effects of COVID-19 vaccination on dialysis patients

COPD patients more compliant with COVID-19 restrictions in the UK

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News